Form D · Biotechnology
Neuralink Corp.
Fremont, CA · CIK 0001708503
Offering snapshot reported Jun 12, 2025 · SEC filing
- Reported sold
- $649M Offering amount: $649M
- Investors reported
- 49 Form D · investor count
- Minimum accepted
- $12K Reported outside-investor minimum
- First sale
- May 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 12, 2025 | Initial | $649,000,093 | No comparison | 49 | SEC filing |
| Nov 22, 2023 | Amendment | $323,241,676 | $42,966,695vs Aug 8, 2023 | 32 | SEC filing |
| Aug 8, 2023 | Initial | $280,274,981 | No comparison | 24 | SEC filing |
| Aug 4, 2021 | Initial | $205,899,985 | No comparison | Not reported | SEC filing |
| May 10, 2019 | Initial | $39,312,497 | No comparison | 7 | SEC filing |
| Aug 25, 2017 | Initial | $26,958,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-548814
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Jun 12, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jared Birchall | Director, Executive |
| Max Hodak | Executive |
| Elon Musk | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7400 Paseo Padre Parkway
Fremont, CA, 94555
Fremont, CA, 94555